TherapeuticsMD to Host Fourth Quarter, Full-Year 2014 Financial Results Conference Call and Webcast

BOCA RATON, Fla.--()--TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women’s healthcare company, today announced that it will hold a conference call and live audio webcast to discuss fourth quarter and full-year 2014 financial and business results on Tuesday, March 10. The conference call and webcast will take place at 4:30 p.m. EDT. TherapeuticsMD CEO Robert G. Finizio and Chief Financial Officer Dan Cartwright will host the call.

Details for the call and webcast include:

Date

  Tuesday, March 10, 2015
Time   4:30 p.m. EDT
Telephone access: U.S. and Canada   866-665-9531
Telephone access: International   724-987-6977
Access code for all callers   91862074
Live audio webcast  

www.therapeuticsmd.com

See home page or “Investor” section

Shortly after completion of the call and webcast, an audio replay and a webcast replay will be available for at least 30 days on the company's website, www.therapeuticsmd.com, in the “Investor” section.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology platform, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins and cosmetics, under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.

Contacts

TherapeuticsMD, Inc.
Investors:
Dan Cartwright, 561-961-1900
Chief Financial Officer
Dan.Cartwright@TherapeuticsMD.com
or
Media:
Julia Amadio, 561-961-1900
Chief Product Officer
Julia.Amadio@TherapeuticsMD.com

Release Summary

TherapeuticsMD, Inc. to host conference call and live audio webcast on Tuesday, March 10 to discuss 2014 financial results.

Contacts

TherapeuticsMD, Inc.
Investors:
Dan Cartwright, 561-961-1900
Chief Financial Officer
Dan.Cartwright@TherapeuticsMD.com
or
Media:
Julia Amadio, 561-961-1900
Chief Product Officer
Julia.Amadio@TherapeuticsMD.com